ID   KDIS_RAT                Reviewed;        1762 AA.
AC   Q9EQG6; Q9ERD4;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   24-JUL-2024, entry version 134.
DE   RecName: Full=Kinase D-interacting substrate of 220 kDa;
DE   AltName: Full=Ankyrin repeat-rich membrane-spanning protein;
GN   Name=Kidins220; Synonyms=Arms;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, PHOSPHORYLATION
RP   AT SER-918, MUTAGENESIS OF SER-918, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH PRKD1.
RX   PubMed=10998417; DOI=10.1074/jbc.m005261200;
RA   Iglesias T., Cabrera-Poch N., Mitchell M.P., Naven T.J.P., Rozengurt E.,
RA   Schiavo G.;
RT   "Identification and cloning of Kidins220, a novel neuronal substrate of
RT   protein kinase D.";
RL   J. Biol. Chem. 275:40048-40056(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH NGFR AND
RP   NTRK1, PHOSPHORYLATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11150334; DOI=10.1523/jneurosci.21-01-00176.2001;
RA   Kong H., Boulter J., Weber J.L., Lai C., Chao M.V.;
RT   "An evolutionarily conserved transmembrane protein that is a novel
RT   downstream target of neurotrophin and ephrin receptors.";
RL   J. Neurosci. 21:176-185(2001).
RN   [3]
RP   FUNCTION, PHOSPHORYLATION, DOMAIN, AND INTERACTION WITH NTRK1; NTRK2; NTRK3
RP   AND CRKL.
RX   PubMed=15167895; DOI=10.1038/sj.emboj.7600253;
RA   Arevalo J.C., Yano H., Teng K.K., Chao M.V.;
RT   "A unique pathway for sustained neurotrophin signaling through an ankyrin-
RT   rich membrane-spanning protein.";
RL   EMBO J. 23:2358-2368(2004).
RN   [4]
RP   INTERACTION WITH NTRK1 AND NGFR.
RX   PubMed=15378608; DOI=10.1002/jnr.20262;
RA   Chang M.-S., Arevalo J.C., Chao M.V.;
RT   "Ternary complex with Trk, p75, and an ankyrin-rich membrane spanning
RT   protein.";
RL   J. Neurosci. Res. 78:186-192(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH SNTA1; SNTB2 AND EPHA4, TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, PHOSPHORYLATION, MOTIF, AND MUTAGENESIS OF SER-1760.
RX   PubMed=15939763; DOI=10.1083/jcb.200412008;
RA   Luo S., Chen Y., Lai K.-O., Arevalo J.C., Froehner S.C., Adams M.E.,
RA   Chao M.V., Ip N.Y.;
RT   "Alpha-syntrophin regulates ARMS localization at the neuromuscular junction
RT   and enhances EphA4 signaling in an ARMS-dependent manner.";
RL   J. Cell Biol. 169:813-824(2005).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH MAGI2; RAPGEF2 AND NTRK1,
RP   INTERACTION WITH RAPGEF2 AND MAGI2, AND SUBCELLULAR LOCATION.
RX   PubMed=17724123; DOI=10.1083/jcb.200610073;
RA   Hisata S., Sakisaka T., Baba T., Yamada T., Aoki K., Matsuda M., Takai Y.;
RT   "Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes,
RT   leading to sustained activation of Rap1 and ERK and neurite outgrowth.";
RL   J. Cell Biol. 178:843-860(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-918; SER-1513 AND SER-1518,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Promotes a prolonged MAP-kinase signaling by neurotrophins
CC       through activation of a Rap1-dependent mechanism. Provides a docking
CC       site for the CRKL-C3G complex, resulting in Rap1-dependent sustained
CC       ERK activation. May play an important role in regulating postsynaptic
CC       signal transduction through the syntrophin-mediated localization of
CC       receptor tyrosine kinases such as EPHA4. In cooperation with SNTA1 can
CC       enhance EPHA4-induced JAK/STAT activation. Plays a role in nerve growth
CC       factor (NGF)-induced recruitment of RAPGEF2 to late endosomes and
CC       neurite outgrowth. May play a role in neurotrophin- and ephrin-mediated
CC       neuronal outgrowth and in axon guidance during neural development and
CC       in neuronal regeneration. {ECO:0000269|PubMed:11150334,
CC       ECO:0000269|PubMed:15167895, ECO:0000269|PubMed:15939763,
CC       ECO:0000269|PubMed:17724123}.
CC   -!- SUBUNIT: Found in a complex, at least composed of KIDINS220, MAGI2,
CC       NTRK1 and RAPGEF2; the complex is mainly formed at late endosomes in a
CC       nerve growth factor (NGF)-dependent manner (PubMed:17724123). Interacts
CC       with RAPGEF2; the interaction is strengthened after NGF stimulation
CC       (PubMed:17724123). Isoform 2 interacts (via C-terminal domain) with
CC       MAGI2 isoform 1 (via PDZ domain) (PubMed:17724123). Interacts with
CC       NTRK1, NTRK2, NTRK3, ERKL and NGFR (PubMed:11150334, PubMed:15167895,
CC       PubMed:15378608). Can form a ternary complex with NGFR and NTRK1 and
CC       this complex is affected by the expression levels of KIDINS220/ARMS
CC       (PubMed:15378608). An increase in KIDINS220/ARMS expression leads to a
CC       decreased association of NGFR and NTRK1 (PubMed:15378608). Interacts
CC       (via PDZ-binding motif) with SNTA1 and SNTB2 (via PDZ domains)
CC       (PubMed:15939763). Interacts with EPHA4 and PRKD1 (PubMed:10998417,
CC       PubMed:15939763). {ECO:0000269|PubMed:10998417,
CC       ECO:0000269|PubMed:11150334, ECO:0000269|PubMed:15167895,
CC       ECO:0000269|PubMed:15378608, ECO:0000269|PubMed:15939763,
CC       ECO:0000269|PubMed:17724123}.
CC   -!- INTERACTION:
CC       Q9EQG6; P46109: CRKL; Xeno; NbExp=2; IntAct=EBI-976654, EBI-910;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Late endosome {ECO:0000269|PubMed:10998417,
CC       ECO:0000269|PubMed:17724123}. Note=Localized at late endosome before or
CC       after nerve growth factor (NGF) stimulation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9EQG6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9EQG6-2; Sequence=VSP_031868, VSP_031869;
CC   -!- TISSUE SPECIFICITY: Expressed in developing nervous system and in
CC       highly plastic areas of the adult brain. Also expressed in
CC       neuroendocrine cells, where it concentrates at the tip of neurites.
CC       Expressed in developing muscle and is concentrated at the neuromuscular
CC       junction (NMS). SNTA1 can regulate its localization in the NMS.
CC       {ECO:0000269|PubMed:10998417, ECO:0000269|PubMed:11150334,
CC       ECO:0000269|PubMed:15939763}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in postmitotic neurons during the stage
CC       of development in which extensive axon pathfinding is occurring. At 14
CC       dpc, expressed in both spinal cord and dorsal root ganglia. Present on
CC       the sarcolemma in postnstal day 1 (P1) gastrocnemius muscle. By P8,
CC       becomes more concentrated at the junctional sites and by P21,
CC       colocalizes with acetylcholine receptor clusters.
CC       {ECO:0000269|PubMed:11150334, ECO:0000269|PubMed:15939763}.
CC   -!- DOMAIN: The transmembrane domain mediates interaction with NTRK1.
CC       {ECO:0000269|PubMed:15167895}.
CC   -!- PTM: Tyrosine phosphorylated by NTRK1, NTRK2, EPHB2 and EPHA4.
CC       Phosphorylation at Ser-918 is induced by phorbol ester treatment.
CC       Phosphorylation by NTRK2 is induced by brain-derived neurotrophic
CC       factor (BDNF) and neurotrophin-4/5. Phosphorylation by NTRK1 is induced
CC       by nerve growth factor (NGF). {ECO:0000269|PubMed:10998417,
CC       ECO:0000269|PubMed:11150334, ECO:0000269|PubMed:15167895,
CC       ECO:0000269|PubMed:15939763}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG34167.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF239045; AAG35185.2; -; mRNA.
DR   EMBL; AF313464; AAG34167.1; ALT_FRAME; mRNA.
DR   RefSeq; NP_446247.1; NM_053795.1.
DR   PDB; 7D6F; X-ray; 2.70 A; B=1748-1762.
DR   PDBsum; 7D6F; -.
DR   AlphaFoldDB; Q9EQG6; -.
DR   SMR; Q9EQG6; -.
DR   CORUM; Q9EQG6; -.
DR   IntAct; Q9EQG6; 5.
DR   STRING; 10116.ENSRNOP00000063889; -.
DR   iPTMnet; Q9EQG6; -.
DR   PhosphoSitePlus; Q9EQG6; -.
DR   SwissPalm; Q9EQG6; -.
DR   jPOST; Q9EQG6; -.
DR   PaxDb; 10116-ENSRNOP00000063889; -.
DR   GeneID; 116478; -.
DR   KEGG; rno:116478; -.
DR   AGR; RGD:619949; -.
DR   CTD; 57498; -.
DR   RGD; 619949; Kidins220.
DR   eggNOG; KOG0502; Eukaryota.
DR   InParanoid; Q9EQG6; -.
DR   OrthoDB; 5474354at2759; -.
DR   PhylomeDB; Q9EQG6; -.
DR   Reactome; R-RNO-170984; ARMS-mediated activation.
DR   Reactome; R-RNO-9696270; RND2 GTPase cycle.
DR   Reactome; R-RNO-9696273; RND1 GTPase cycle.
DR   PRO; PR:Q9EQG6; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IDA:RGD.
DR   GO; GO:0019887; F:protein kinase regulator activity; IDA:RGD.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0038180; P:nerve growth factor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:UniProtKB.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 2.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011646; KAP_P-loop.
DR   InterPro; IPR052771; Neurotrophin_sig_adaptor.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR24116; KINASE D-INTERACTING SUBSTRATE OF 220 KDA; 1.
DR   PANTHER; PTHR24116:SF0; KINASE D-INTERACTING SUBSTRATE OF 220 KDA; 1.
DR   Pfam; PF00023; Ank; 2.
DR   Pfam; PF12796; Ank_2; 3.
DR   Pfam; PF13637; Ank_4; 1.
DR   Pfam; PF07693; KAP_NTPase; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 11.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 10.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; Endosome; Membrane;
KW   Neurogenesis; Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..1762
FT                   /note="Kinase D-interacting substrate of 220 kDa"
FT                   /id="PRO_0000322120"
FT   TOPO_DOM        1..508
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        509..529
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        530..533
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        534..554
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        555..668
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        669..689
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        690..696
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        697..717
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        718..1680
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          45..74
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          78..107
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          111..140
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          145..174
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          178..207
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          211..240
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          244..273
FT                   /note="ANK 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          277..306
FT                   /note="ANK 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          310..339
FT                   /note="ANK 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          343..372
FT                   /note="ANK 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          376..405
FT                   /note="ANK 11"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          440..953
FT                   /note="KAP NTPase"
FT   REGION          1089..1092
FT                   /note="Mediates interaction with CRKL"
FT                   /evidence="ECO:0000269|PubMed:15167895"
FT   REGION          1279..1305
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1336..1358
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1390..1440
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1452..1556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1571..1628
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1704..1762
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1757..1762
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000269|PubMed:15939763"
FT   COMPBIAS        1337..1358
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1390..1422
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1423..1440
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1523..1556
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1580..1594
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1595..1618
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1705..1755
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         882
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         885
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         914
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         918
FT                   /note="Phosphoserine; by PKD"
FT                   /evidence="ECO:0000269|PubMed:10998417,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         1163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1357
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1513
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1518
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1547
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1566
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1615
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1625
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1671
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1673
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   MOD_RES         1676
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULH0"
FT   VAR_SEQ         135
FT                   /note="L -> LQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11150334"
FT                   /id="VSP_031868"
FT   VAR_SEQ         1139..1187
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11150334"
FT                   /id="VSP_031869"
FT   MUTAGEN         918
FT                   /note="S->A: Loss of phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:10998417"
FT   MUTAGEN         1760
FT                   /note="S->D: Loss of binding to PDZ domain of SNTA1 and
FT                   SNTB2."
FT                   /evidence="ECO:0000269|PubMed:15939763"
FT   CONFLICT        519
FT                   /note="T -> P (in Ref. 2; AAG34167)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1001
FT                   /note="I -> M (in Ref. 2; AAG34167)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1220
FT                   /note="S -> N (in Ref. 2; AAG34167)"
FT                   /evidence="ECO:0000305"
FT   STRAND          1758..1761
FT                   /evidence="ECO:0007829|PDB:7D6F"
SQ   SEQUENCE   1762 AA;  195716 MW;  0CB2689A571F8AE4 CRC64;
     MSVLISQSVI NYVEEENIPA LKALLEKCKD VDERNECGQT PLMLAAEQGN VEIVKELLKN
     GANCNLEDLD NWTALISASK EGHIHIVEEL LKSGASLEHR DMGGWTALMW ACYKGRTDVV
     ELLLSHGANP SVTGLYSVYP IIWAAGRGHA DIVHLLLQNG AKVNCSDKYG TTPLVWAARK
     GHLECVKHLL AMGADVDQEG ANSMTALIVA VKGGYTQSVK EILKRNPNVN LTDKDGNTAL
     MIASKEGHIE IVQDLLDAGT YVNIPDRSGD TVLIGAVRGG HVEIVRALLQ KYADIDIRGQ
     DNKTALYWAV EKGNATMVRD ILQCNPDTEI CTKDGETPLI KATKMRNIEV VELLLDKGAK
     VSAVDKKGDT PLHVAIRGRS RRLAELLLRN PKDGRLLYRP NKAGETPYNI DCSHQKSILT
     QIFGARHLSP TETDGDMLGY DLYSSALADI LSEPTMQPPI CVGLYAQWGS GKSFLLKKLE
     DEMKTFAGQQ TEPLFQFSWL IVFLTLLLCG GLGLVFAFTV DTNLAIAISL SFLALIYIFF
     IVIYFGGRRE GESWNWAWAL STRLARHIGY LELLFKLMFV NPPELPEQTT KALPVRFLFT
     DYNRLSSVGG ETSLAEMIAT LSDACEREFG FLATRLFRVF RTEESQGKKK WKKTCCLPSF
     VIFLFIVGCI IAGITLLAIF RVDPKHLTVN AILISIASVV GLAFVLNCRT WWQVLDSLLN
     SQRKRLHSAA SKLHKLKSEG FMKVLKCEVE LMARMAKTID SFTQNQTRLV VIIDGLDACE
     QDKVLQMLDT VRVLFSKGPF IAIFASDPHI IIKAINQNLN SVLRDSNING HDYMRNIVHL
     PVFLNSRGLS NARKFLVTSA TNGDITCSDT TGTQEDTDRR VSQNSLGEMT KLGSKTALNR
     RDTYRRRQMQ RTITRQMSFD LTKLLVTEDW FSDISPQTMR RLLNIVSVTG RLLRANQITF
     NWDRLASWIN LTEQWPYRTS WLILYLEETE GLPDQMTLKT IYERISKNIP TTKDVEPLLE
     IDGDIRNFEV FLSSRTPVLV ARDVKTFLPC TVNLDPKLRE IIADVRAARE QINIGGLAYP
     PLPLHEGPPR PPSGYSQPAS VCSSASFNGP FPGGVVSPQP HSSYYSGLSG PQHPFYNRPF
     FAPYLYTPRY YPGGSQHLIS RSSVKTSLPR DQNNGLPCDS GFNKQRQAAV PATGSSLLLS
     SMTVDVVCEK LRQIEGLDQS MMPQYCTTIK KANINGRVLS QCNIDELKKE MAMNFGDWHL
     FRSMVLEMRS VESQVVPEDP RFLNENSSAP VPHGESARRS SHTELPLTEL SSQTPYTLNF
     SFEELNTLGL DEGAPRHSNL SWQSQTRRTP SLSSLNSQDS SIEISKLTDK VQAEYRDAYR
     EYIAQMSQLE GGTGSSTISG RSSPHSTYYI GQSSSGGSIH STLEQERGKE GELKQEDGRK
     SFLMKRGDVI DYSSSGVSTN EASPLDPITE EDEKSDQSGS KLLPGKKSSE RPSLFQTDLK
     LKGGGLRYQK LPSDEDESGT EESDNTPLLK DDKDKKAEGK AERVCKSPEH SAEPIRTFIK
     AKEYLSDALL DKKDSSDSGV RSNESSPNHS LHNEAADDSQ LEKANLIELE DEGHSGKRGM
     PHSLSGLQDP IIARMSICSE DKKSPSECSL IASSPEESWP ACQKAYNLNR TPSTVTLNNN
     TAPTNRANQN FDEIEGIRET SQVILRPGPS PNPTAVQNEN LKSMAHKRSQ RSSYTRLSKD
     ASELHAASSE STGFGEERES IL
//
